KEVIN DINSMORE: Open Payments
NPI 1447625785 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 69 payments from 10 companies in 2025. Trend: 2023 $208 · 2024 $285 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 10 | $257 |
| Collegium Pharmaceutical, Inc. | 15 | $251 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $192 |
| SCILEX PHARMACEUTICALS INC. | 17 | $191 |
| Valinor Pharma, LLC | 6 | $121 |
| SI-BONE, INC. | 1 | $73 |
| Azurity Pharmaceuticals, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| ABBVIE INC. | 1 | $14 |
Products named: PURIFIED CORTROPHIN GEL, Belbuca, RELISTOR, ZTLido, MOVANTIK, HORIZANT, ELYXYB - CELECOXIB, Symbravo.
Industry payments across CT — which companies pay providers there.
